secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001437749-24-032705
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx subsidiary HOPE signs non-binding LOI to acquire Florida Interventional Psychiatry Clinics
--------------------------------------------------------------------------------

- HOPE Therapeutics, NRx subsidiary, signs LOI for first Interventional Psychiatry Clinics in Florida.
- Clinics are revenue generating and EBITDA positive; acquisition expected to be immediately accretive.
- Acquisition subject to definitive documentation and receipt of adequate financing.
- Clinics will form foundation for HOPE's growth in Florida; founders to help optimize additional acquisitions.
- NRx and HOPE aim to establish a model for CNS care clinics nationwide.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774924032705/0001437749-24-032705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774924032705/nrxp20241031_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-032705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer